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1 INTRODUCTION
Development of molecular biomarkers and molecular therapeutics forms the basis for the personalized
cancer medicine in the 21st century. Now the cancer therapy is changing from a “one size fits all”
approach to more personalized one, in which each patient is treated according to the genetic defects in his
tumor. Identification and characterization of specific gene expression profiles (socalled geneexpression
signatures) in tumors is a significant contribution to understanding of the molecular features of malignan
cies, mechanisms of their arising and development.
Individual molecular markers have limited significance for the diagnostic evaluation of tumors due to
the high heterogeneity of their biological properties, and only simultaneous analysis of changes in many
marker genes can characterize individual tumor reliably. Despite some differences in the multigene signa
tures, gene profiles for the same tumor types have similar distribution on functional groups that can give
similar prognostic information. In an effort to identify genes, which might be used as molecular markers
for glial tumors, we compared gene expression in glioblastoma and normal adult human brain. Obtained
results demonstrated 129 genes with more than 5fold change of expression in tumors compared to the
normal brain cells [1]. Further characterization of these genes will result in the development of socalled
cDNApanels, which can be used for molecular typing of human brain tumors, i.e. determination of cer
tain molecular variants for the tumors of identical histological type may serve for diagnostics and as targets
for molecular therapy. 
There are several examples of signatures developed for prognostic evaluation of the definite cancer
types. 70gene signature was tested successfully on the big group of patients for the prognostic evaluation
of breast cancer [2]. Another research group independently identified a 76gene signature by similar
approach [3]. 16gene signature was identified also using 250 genes tested on 400 tumors [4]. Amongst all
geneexpression signatures that have been identified up to now, only three are commercially available: the
70gene signature for breast cancer prognosis under the name MammaPrint (Agendia); the 16gene sig
1 The article is published in the original.
47glioblastoma Gene Expression Profile Diagnostics 
by the Artificial Neural Networks1
Y. A. Kuperina, A. A. Meklerb, I. Kniazevac, D. R. Schwartzd, V. V. Dmitrenkoe, 
V. I. Rimare, and V. M. Kavsane
aSaint Petersburg State University, Saint Petersburg, Russia
bInstitute of Human Brain, Russian Acad. Sci., Saint Petersburg, Russia
cCentral Astronomical Observatory at Pulkovo, Russian Acad. Sci., Saint Petersburg, Russia
dSaint Petersburg State Polytechnical University, SaintPetersburg, Russia
eThe Institute of Molecular Biology and Genetics of NASU, Kiev, Ukraine
email: mekler@narod.ru 
Received April 5, 2010; in final form, April 16, 2010
Abstract—Two artificial neural networks of different types were applied to profiles of gene expression
in most aggressive human brain tumor – glioblastoma – and in normal brain tissue. The results of gene
expression profiles classification are presented. First method – self organizing maps – gave good dis
crimination of profiles on the trained map. Another ANN – perceptron – showed a good result of
classification – more then 95% of the test data set were successfully classified. Due to high correlations
between some gene expression values one can suppose, that number of genes necessary for successful
classification may be reduced.
Key words: Glioblastoma, gene, artificial intelligence, perceptron, selforganizing maps.
DOI: 10.3103/S1060992X10020098
182
OPTICAL MEMORY AND NEURAL NETWORKS (INFORMATION OPTICS)  Vol. 19  No. 2  2010
KUPERIN et al.
nature as Oncotype DX (Genomic Health); and a 2gene signature, which has been recently released,
under the name the H/I test (AviaraDx) [5].
Artificial neural networks were used in some cases for the classification of genes according to their expres
sion. For example, such approach was used for prostate cancer [6]. Changes of gene expression profile during
the diauxic shift in Saccharomyces cerevisiae were characterized by Kohonen selforganizing map [7]. This
method was considered as one of the alternatives for the differential diagnostics of leukemia [8].
Today, there is no similar commercial signature for glial tumors, although several publications
described the gene expression profiles allowing to characterize differences mostly between glioblastoma
and normal brain [9, 10], including the implementing of artificial neural map [11] were published. How
ever, the identification of geneexpression signature for glioblastoma, which can be used for molecular
typing and prognostic evaluation of glial tumors, is an actual problem still. It has theoretical as well as
practical importance.
PROBLEM DEFINITION AND DATA DESCRIPTION
The main task of the study is revelation of group of genes, which expression profiles are most easy to
be classified by means of ANN with the purpose of diagnostics of some oncological diseases. One of the
most important subtasks of this task is the clusterization of the group of subjects into two subgroups –
healthy and ill – judging the levels of expression of the genes set. In the present work this task is performed
implementing Kohonen selforganized maps and multilayer perceptron. Selection of the genes for classi
fication is performed using database of two modern methods of the expressive genetics – series analysis of
the gene expression (SAGE) and microchip analysis. Database included two sets of vectors corresponding
to healthy subjects and patients. Each subject was represented by the vector, each component of which had
a value of the respective gene expression. In total training set value was 296 vectors. 71 of them were from
the healthy people, all the rest – from glioblastoma patients. Vectors dimension was 20 – according to
number of genes under study. 
The input data format is shown in the Table 1. In this table column “Name” contains encoded names
of subjects while codes CAMK2B (#1), STMN2 (#2) and so on – codes of genes and their indexes in pro
file – 20 genes in total.
In the beginning of our study we performed correlation analysis of data. It was found out, that expres
sion values of some genes are highly correlated. Correlations in the group of healthy tissue differed from
correlations in the glioblastoma (Fig. 1). This says about possibility of reliable clusterization of gene pro
files by SOM or perceptrons.
DATA CLUSTERIZATION BY SOM
A selforganizing map (SOM) [12] is a neural network algorithm that reduces the dimension of a data
set while being topologypreserving, i.e., proximity of cases in highdimensional space is preserved in the
space of reduced dimensionality. Typically, data dimension is reduced to two dimensions for easy visual
ization. The SOM algorithm works by arranging artificial neurons on a twodimensional grid, with each
neuron being connected to its neighbors. This grid is then reshaped according to the similarity of cases in
order to reflect the highdimensional data distribution. This is very important for medicine diagnostics
because it gives opportunity observe patients with similar gene expression and compare their medical
reports.
Table 1.  Input data format
N Name CAMK2B (#1) STMN2 (#2) … PSMB8 (#19) KIF20 A (#20)
1 GSM97800 1.83 1.47 … 0 0
2 GSM97803 1.69 1.14 … 0 0
… … … … … … …
295 GSM96975 0.44 0.03 … 0.11 0.03
296 GSM96986 0.1 0.79 … 0.25 0.08
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SOM TRAINING PARAMETERS 
SELECTION
The practice of SOM implementation shows
some difficulties. Different program realiza
tions [13–17] lead to different results on the
same training data sets. Different training
parameters also can lead to different results.
This can be related with the program realization
of method, the initialization of SOM, the num
ber of neurons, the choice of neighborhood
function, the initial and finite radius of training,
etc. In order to identify the right way of realiza
tion in the aspect of solving the FCP (Funda
mental Clustering Problem) tasks we compared
the most of available softwarebased implemen
tations of SOM algorithm [18]. As a result we
used in our research a batch realization of the
algorithm in Matlab SOM Toolbox. Also it
should be noted that the choice of network
parameters and parameters of its training is a
crucial stage of the training. For example if the
number of neurons is too large, then overtrain
ing is possible, when the nodes of the network
“stick” to each input vector. The effect of over
training makes the network lose its smoothness –
the generalizing ability. Elastic resilient maps
[14] are in certain way the analog of SOM where
the parameters of the network flexibility and
elasticity regulating are applied.
It is possible to control the SOM overtrain
ing without test dataset by means of training
cessation when the neighborhood radius
becomes smaller than radius Rρ (1) (2D rect
angle topology).
(1)
where SOMSize – size of network; DataLen –
length of training data.
Finally, at the last stage of training there is a
competition between the winner neurons for
the data which fall between them. This leads to
the smoothing of the space between the winner
Rρ
SOMSize
DataLen
,≈
neurons. The detailed method description is in [17]. 
The SOM initialization is performed in the space of two main components. The initial radius of train
ing is selected in the following way:
(2)
Here XSize and Ysize are the sizes of the sides of rectangular network, SOMSize = XSize × Ysize.
SOM TRAINING RESULTS
After the Kohonen map training was completed, the vectors corresponding to normal gene expression
profiles were pictured on the map as white marks, and to the pathological – as black marks. The parameters
of SOM were the following: topology – 2D sheet, bond type – rectangular, number of neurons 50 × 50, ini
tial training radius – 1500, final training radius – 3, neighborhood function – Gaussian. Fig. 2 shows the
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Fig. 1. Correlations between gene expression values. a)
glioblastoma; b) normal tissue.
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marks distribution throughout the map after its training. One can see that the data set is divided into two
big groups (normal and glioblastoma).
The winner neurons with frequencies 2 or more (2 or more profiles mapped onto them) may be the
most of interest for further study, because they contain data with very similar patterns. Neurons placed in
the opposite corners of the map correspond to the most different profiles of gene expression. Some profiles
mapped onto the “wrong” area – normal onto the “pathological” area and vice versa. This can be
explained by insufficient informativeness of the inputs or wrong diagnosis, as well as by individual pecu
liarities of people under study.
Figure 3 shows typical gene expression profiles in normal tissue and glioblastoma that were mapped
respectively onto neurons A and B in two clusters on Fig. 3.
Classification by the TwoLayer Feedforward Neural Network
We used twolayer feedforward artificial neural network for this classification task. We choose neural
network with 20 neurons in hidden layer and hyperbolic tangent as an activation function, and two neu
rons in output layer with linear activation function. Input data set was divided into the training, validation
and test subsets in proportion 60% : 20% : 20% respectively. Feature vector of dimension 20 was used as
an input vector. Output vector consists of two elements. Their values are [0 1] when input vector represents
healthy tissue or [1 0] when it is glioblastoma. The results of classification are shown in the Table 2.
A
B
Fig. 2. Marks distribution throughout the map.
Table 2.  The results of gene expression profiles classification by feed forward neural network
Sample size
Training set Validation set Test set
Normal tissue (total) 160 32 33
Normal tissue (misclassified as glioblastoma) 1 (0.6%) 0 1 (3%)
Glioblastoma (total) 48 12 11
Glioblastoma (misclassified as normal) 1 (2.1%) 0 0
Overall classification error 2 (0.96%) 0 1 (2.3%)
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CONCLUSIONS
Performed study shows that applied methods allow discriminating data set into two parts – normal and
pathology – with quite high reliability. This means, that datasets, we used, have been well prepared. High
correlations between gene expression values (Fig. 1) show, that number of genes may be reduced.
In the future we are going to reduce training vector dimensionality. This may be done by different
means: mutual entropy reduction, principal components extraction etc. We are planning to make such a
data preprocessing on the next step of our study. Also, we are planning to include in data analysis infor
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Fig. 3. Gene expression profiles in the healthy tissue (neuron A) and glioblastoma (neuron B). Several profiles were
mapped onto each of these neurons. Xaxis – index of genes in profile. Yaxis – gene expression value.
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mation about expression of more genes. We intent to get in this way more detailed information from SOM
aiming the possibility of typologization of tumors and their prognostic assessment.
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